Participant characteristics
ADVERSE REACTIONS
A total of 172 participants were included: 82 in the DG and 90 in the NDG. During the 1‐week drug adaptation and follow‐up period, there were 17 further exclusions because of adverse reactions (Participant participation flow chart.There were no clinically significant differences in baseline data characteristics between the DG and the NDG (Table Baseline characteristics of participants to doxophylline group and non‐doxophylline group.Non‐doxophylline group(Doxophylline group(
Mean ± SD.Median (interquartile range).